Press Releases
-
Jun12
Cancer Genetics Strengthens Management Team with Appointment of Michael McCartney as Chief Commercial Officer
Executive appointment underscores continued execution of new corporate strategy of expanding Biopharma and Discovery
-
May15
Cancer Genetics Reports First Quarter 2018 Financial Results and Provides Strategic Business Updates
Conference call at 8:30 a.m. EDT, Tuesday, May 15, 2018 RUTHERFORD, N.J., May 15, 2018 (GLOBE NEWSWIRE) -- Cancer
-
May10
Cancer Genetics to Report First Quarter 2018 Financial Results on May 15, 2018
Conference call at 8:30 a.m. EDT, Tuesday, May 15, 2018 RUTHERFORD, N.J., May 10, 2018 (GLOBE NEWSWIRE) -- Cancer
-
Apr27
Cancer Genetics Announces Sale of India Operations to REPROCELL Incorporated
Execution of 2018 Transformation Plan is on Target RUTHERFORD, N.J., April 27, 2018 (GLOBE NEWSWIRE) -- Cancer
-
Apr16
Cancer Genetics’ Unique Tissue of Origin Test (TOO®) Receives Special FDA 510(k) Clearance
RUTHERFORD, N.J., April 16, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling
-
Apr2
Cancer Genetics Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Strategic Business Updates
Conference call at 4:30 p.m. EDT, Monday, April 2, 2018 RUTHERFORD, N.J., April 02, 2018 (GLOBE NEWSWIRE) -- Cancer
-
Mar26
Cancer Genetics to Host Fourth Quarter and Full Year 2017 Financial Results
Conference call at 4:30 p.m. EDT, Monday, April 2, 2018 RUTHERFORD, N.J., March 26, 2018 (GLOBE NEWSWIRE) -- Cancer
-
Feb5
Cancer Genetics, Inc. Chief Executive Officer Steps Down
• Board Appoints COO, Jay Roberts, Interim Chief Executive Officer RUTHERFORD, N.J., Feb. 05, 2018 (GLOBE
-
Jan17
Cancer Genetics Expands Its Industry-Leading Immuno-Oncology Panel, Complete::IO™, to be the Most Comprehensive for Immune Profiling & Monitoring
- Simultaneously Assesses 27 Unique Immune Markers - Determines Optimal IO Therapies and Tracks Response and
-
Dec28
Cancer Genetics Receives Non-Dilutive Funding of $1.1 Million through New Jersey Technology Business Tax Certificate Transfer (NOL) Program
RUTHERFORD, N.J., Dec. 28, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling
